Cited by 161Pregnancy and Medication ImpactMaternal Mental Health During Pregnancy and PostpartumReproductive Health and Contraception

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

National trends in antidepressant medication treatment among publicly insured pregnant women

Open access

Huybrechts, Krista F., Palmsten, Kristin, Mogun, Helen, Kowal, Mary, Avorn, Jerry, Setoguchi-Iwata, Soko, Hernández-Díaz, Sonia·2013·General Hospital Psychiatry

DOI 10.1016/j.genhosppsych.2012.12.010PMC PMC4077674

Open this paper in CoChat — free account

Abstract

Objective The risk of depression in women is greatest at childbearing age. We sought to examine and explain national trends in antidepressant use in pregnant women.Methods This was a cohort study including pregnant women aged 12-55 who were enrolled in Medicaid during 2000-2007. We examined the proportion of women taking antidepressants during pregnancy by patient characteristics (descriptive), by region (mixed-effects model) and over time (interrupted time series).Results We identified 1,106,757 pregnancies in 47 states; mean age was 23 years, and 60% were nonwhite. Nearly 1 in 12 used an antidepressant during pregnancy. Use was higher for older (11.2% for age ≥30 vs. 7.6% for <30) and white (14.4% vs. 4.0% for nonwhite) women. There was a four- to fivefold difference in rate of antidepressant use among states. Of the 5.3% of women taking antidepressants at conception, 33% and 17% were still on treatment 90 and 180 days, respectively, into pregnancy; an additional 4% began use during pregnancy. Labeled pregnancy-related health advisories did not appear to affect antidepressant use.Conclusions Antidepressant use during pregnancy remains high in this population; treatment patterns vary substantially by patient characteristics and region. Comparative safety and effectiveness data to help inform treatment choices are needed in this setting.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.genhosppsych.2012.12.010

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Segmented regression analysis of interrupted time series studies in medication use research
Wagner, A. K., Soumerai, S. B., Zhang, F., & Ross-Degnan, D. (2002) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2002.00430.x · Cited by 3,279 · cited 2×
“This number is not based on estimates of power, but has been suggested because it allows the analyst to adequately evaluate seasonal variation [33].”
BackgroundMethod
Recent Patterns of Medication Use in the Ambulatory Adult Population of the United States: The Slone Survey
Kaufman, D. W., Kelly, J. P., Rosenberg, L., Anderson, T. E., & Mitchell, A. A. (2002) · JAMA · doi:10.1001/jama.287.3.337 · Cited by 1,845
The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.979 · Cited by 1,485 · cited 1×
“The lifetime risk of depression in women is 10%–25%, twice that in men [1].”
Background
Cohort study of depressed mood during pregnancy and after childbirth
Evans, J., Heron, J., Francomb, H., Oke, S., & Golding, J. (2001) · BMJ · doi:10.1136/bmj.323.7307.257 · Cited by 1,273
Relapse of Major Depression During Pregnancy in Women Who Maintain or Discontinue Antidepressant Treatment
Cohen, L. S. (2006) · JAMA · doi:10.1001/jama.295.5.499 · Cited by 1,031
Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005359 · Cited by 986
The National Depressive and Manic-Depressive Association Consensus Statement on the Undertreatment of Depression
Hirschfeld, R. M. A. (1997) · JAMA · doi:10.1001/jama.277.4.333 · Cited by 896
Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
Chambers, C., Hernández–Dı́az, S., Marter, L. J. V., Werler, M. M., Louik, C., Jones, K. L., & Mitchell, A. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052744 · Cited by 877
Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008
Mitchell, A. A., Gilboa, S. M., Werler, M. M., Kelley, K. E., Louik, C., & Hernández–Dı́az, S. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.02.029 · Cited by 813
Birth Outcomes in Pregnant Women Taking Fluoxetine
Chambers, C., Johnson, K. A., Dick, L. M., Felix, R. J., & Jones, K. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351402 · Cited by 735

Flagged first, then by citations

Show all 38 references

Research works printed but not linked: 2

Palmsten, 2011, Medicaid Analytic eXtract for studies of drug safety during pregnancy, Pharmacoepidemiol Drug Saf, 20, S266
Margulis, 2010, A claims-based algorithm to estimate the date of the last menstrual period, Pharmacoepidemiol Drug Saf, 19, s300

Sorted by citations

Items 101–161 of 161

Perceptual interference processing in preschool children, with and without prenatal exposure to selective serotonin reuptake inhibitors
Hermansen, T. K., Yrttiaho, S., Røysamb, E., & Melinder, A. M. D. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4467-7 · Cited by 10
The effects of perinatal fluoxetine exposure on emotionality behaviours and cortical and hippocampal glutamatergic receptors in female Sprague-Dawley and Wistar-Kyoto rats
Millard, S. J., Lum, J. S., Fernandez, F., Weston–Green, K., & Newell, K. A. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110174 · Cited by 11
Reduced Motivation in Perinatal Fluoxetine-Treated Mice: A Hypodopaminergic Phenotype
Menezes, E. D. C., Shah, R., Laughlin, L. C., Vinod, K. Y., Smiley, J. F., Cunha, C., Balla, A., Sershen, H. W., Castellanos, F. X., Corvelo, A., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2608-20.2021 · Cited by 9
School-age social behavior and pragmatic language ability in children with prenatal serotonin reuptake inhibitor exposure
Smearman, E., Hendrix, C. L., Winiarski, D. A., Johnson, K. C., Smith, A. K., Ousley, O., Stowe, Z. N., Newport, D. J., & Brennan, P. A. (2019) · Development and Psychopathology · doi:10.1017/s0954579418001372 · Cited by 9
Using nationally representative survey data for external adjustment of unmeasured confounders: An example using the NHANES data
Hernández–Dı́az, S., Bateman, B. T., Palmsten, K. K., Schneeweiß, S., & Huybrechts, K. F. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4946 · Cited by 8
Association of Antidepressant Continuation in Pregnancy and Infant Birth Weight
Wartko, P. D., Weiss, N. S., Enquobahrie, D. A., Chan, K. C. G., Stephenson‐Famy, A., Mueller, B. A., & Dublin, S. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001410 · Cited by 8
Prenatal exposure to vortioxetine and vilazodone: Impact on depressive- and anxiety-like behavioral manifestations in young rat offspring
Singh, P., Agrawal, P., & Singh, K. P. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115128 · Cited by 8
The association of cannabis use late in pregnancy with engagement and retention in perinatal substance use disorder care for opioid use disorder: A cohort comparison
Galvin, S. L., Ramage, M., Mazure, E. S., & Coulson, C. C. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.108098 · Cited by 7
General Approach to Pharmacological Treatment: During the Perinatal Period
Bellantuono, C., Martellini, M., & Orsolini, L. (2019) · Springer eBooks · doi:10.1007/978-3-319-92919-4_4 · Cited by 6
Gestational exposure to antidepressants and risk of seizure in offspring: A systematic review and meta-analysis
Leung, M. T. Y., Wong, K. H. T. W., Ho, P. W. H., Ip, P., Wei, L., Wong, I. C. K., & Man, K. K. C. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.040 · Cited by 6
Antidepressant Prescriptions Increased For Privately Insured People With Perinatal Mood And Anxiety Disorder, 2008–20
Hall, S. V., Pangori, A., Tilea, A. M., Schroeder, A., Admon, L. K., & Zivin, K. (2024) · Health Affairs · doi:10.1377/hlthaff.2023.01448 · Cited by 5
Postpartum Psychiatric Outcomes and Sick Leave After Discontinuing SSRI or SNRI in Pregnancy
Cesta, C. E., Reutfors, J., Cohen, J. M., Eriksson, J. A., Furu, K., Zoëga, H., & Pazzagli, L. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.38269 · Cited by 5
Are we overlooking the obvious? Addressing social determinants of health that contribute to perinatal depression
Simhi, M., & Yoselis, A. (2022) · Australian Journal of Primary Health · doi:10.1071/py22002 · Cited by 5
Placental glucocorticoid receptors are not affected by maternal depression or SSRI treatment
Edvinsson, Å., Hoyer, A., Hansson, M., Kallak, T. K., Poromaa, I. S., Skalkidou, A., & Lager, S. (2020) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2019.1702126 · Cited by 5
In utero and lactational exposure to the Selective Serotonin Reuptake Inhibitor fluoxetine compromises pup bones at weaning
Weaver, S. R., Xie, C., Charles, J. F., & Hernandez, L. L. (2019) · Scientific Reports · doi:10.1038/s41598-018-36497-8 · Cited by 5
Lactational exposure to venlafaxine provokes late repercussions on reproductive parameters in male rat offspring
Moreira, S. D. S., Manoel, B. D. M., Inácio, J. P. G., de Souza, C. G., Reis, A. C. C., Jorge, B. C., de Aquino, A. M., Scarano, W. R., Cardoso, C. A. L., & Arena, A. C. (2022) · Journal of Applied Toxicology · doi:10.1002/jat.4389 · Cited by 5
Do sex and gender matter in the pharmacological treatment of depression?
Seifert, J. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04611-z · Cited by 3
Examining Associations Between the Timing of Maternal Depressive Symptoms, Parenting Behaviors, and Child Outcomes
Redic, M. M., Luby, J. L., Constantino-Pettit, A. M., Triplett, R. L., Gerstein, E. D., Ruscitti, M., Loseille, D., Alexopoulos, D., Smyser, T. A., Rogers, C. E., et al. (2025) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2025.12.010 · Cited by 4
Neurobehavioral Follow-Up of Children Exposed to Selective Serotonin Reuptake Inhibitors in Utero
Cohen, L. S., Rhodes, S., Claypoole, L. D., Góez-Mogollón, L. M., Sosinsky, A. Z., Moustafa, D., Noe, O. B., McElheny, S. A., Cheng, L. J., Bick, J. R., et al. (2022) · Annals of Clinical Psychiatry · doi:10.12788/acp.0074 · Cited by 4
Association of maternal personality traits with medication use during pregnancy to appraise unmeasured confounding in long-term pharmacoepidemiological safety studies
Lupattelli, A., Trinh, N. T., & Nordeng, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1160168 · Cited by 4
Perinatal depression before and during the COVID-19 pandemic in New York City
Lantigua-Martinez, M. V., Trostle, M. E., Torres, A. M., Rajeev, P. T., Dennis, A., Silverstein, J. S., & Talib, M. (2023) · AJOG Global Reports · doi:10.1016/j.xagr.2023.100253 · Cited by 4
Maternal Daphnia magna exposure to the antidepressant sertraline causes molting disorder, multi-generational reproductive and serotonergic dysfunction
Dong, C., Wang, L., Barulin, N. V., Alava, J. J., Liu, S., & Xiong, D. (2024) · Aquatic Toxicology · doi:10.1016/j.aquatox.2024.107161 · Cited by 4
Prenatal Antidepressant Exposure and Risk of Depression and Anxiety Disorders: An Electronic Health Records–Based Cohort Study
Talati, A., Voort, J. L. V., White, L. J., Hodge, D. O., Stoppel, C. J., Weissman, M. M., Gingrich, J. A., & Bobo, W. V. (2025) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2025.03.026 · Cited by 4
Timing of selective serotonin reuptake inhibitor use and risk for preterm birth and related adverse events: with a consideration of the COVID-19 pandemic period
Hwang, Y. M., Roper, R. T., Piekos, S. N., Enquobahrie, D. A., Hebert, M. F., Paquette, A. G., Baloni, P., Price, N. D., Hood, L., & Hadlock, J. (2024) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2024.2313364 · Cited by 5
Depression Screening During Pregnancy and the Postpartum Period: Enhancing Informed Consent Practices
Vaswani, A., Karter, J. M., Cosgrove, L., Peters, S. M., & Brodt, M. (2018) · Women s Reproductive Health · doi:10.1080/23293691.2018.1429532 · Cited by 4
Treatment of Maternal Depression With In-Home Cognitive Behavioral Therapy Augmented by a Parenting Enhancement: A Case Report
Messer, E. P., Ammerman, R. T., Teeters, A. R., Bodley, A. L., HOWARD, J. M., Ginkel, J. B. V., & Putnam, F. W. (2017) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2017.10.002 · Cited by 3
Epidemiology of the Use of Psychotropic Drugs in Pregnant and Nursing Women
Alwan, S. S., & Bérard, A. (2019) · Springer eBooks · doi:10.1007/978-3-319-92919-4_1 · Cited by 3
Psychotropic medication use during pregnancy and gestational age at delivery
Haviland, M. J., Nillni, Y. I., Fox, M. P., Savitz, D. A., Hatch, E. E., Rothman, K. J., Hacker, M. R., Wang, T. R., & Wise, L. A. (2020) · Annals of Epidemiology · doi:10.1016/j.annepidem.2020.08.010 · Cited by 3
Maternal Depression and Antidepressant Use During Pregnancy and Associations with Depressive Symptoms and Suicidality in Adolescent Children
Beck‐Pancer, D., Aghaee, S., Swint, A., Acker, J., Deardorff, J., & Kubo, A. (2023) · Clinical Epidemiology · doi:10.2147/clep.s380894 · Cited by 3
Toxicity to the Insulin-Secreting β-Cell
Long, N. E. D., & Holloway, A. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95676-9 · Cited by 2
Maternal exposure to fluoxetine during gestation and lactation does not alter plasma concentrations of testosterone, oestrogen or corticosterone in peripubertal offspring
Barbosa, M. A., Veríssimo, L. F., Gerardin, D. C. C., Pelosi, G. G., Ceravolo, G. S., & Moreira, E. G. (2019) · Reproduction Fertility and Development · doi:10.1071/rd18279 · Cited by 2
The effect of yoga on maternal stress and anxiety: A systematic review
Schlegel, R. (2020) · The Journal of Health Design · doi:10.21853/jhd.2020.94 · Cited by 2
Maternal Gestational Weight Gain in Relation to Antidepressant Continuation in Pregnancy
Wartko, P. D., Weiss, N. S., Enquobahrie, D. A., Chan, K. C. G., Stephenson‐Famy, A., Mueller, B. A., & Dublin, S. (2020) · American Journal of Perinatology · doi:10.1055/s-0040-1713652 · Cited by 2
Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure
Vaidya, R., Hashmi, N., Kakshapati, S., Chang, W. W., & BEACHY, J. C. (2024) · Journal of Neonatal-Perinatal Medicine · doi:10.3233/npm-230165 · Cited by 2
Prenatal Selective Serotonin Reuptake Inhibitor Exposure and Child Neurodevelopment: The Importance of Maternal Mental Illness
Brown, H. K. (2018) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2018.01.002 · Cited by 2
Epidemiology of Use of Psychotropic Drugs in Pregnant and Nursing Women
Alwan, S. S., & Bérard, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-99720-4_1 · Cited by 1
Psychiatric visits during the postpartum year in women with eating disorders who continue or discontinue antidepressant treatment in pregnancy
Trinh, N. T., Semark, B. D., Munk‐Olsen, T., Liu, X., Rø, Ø., Bulik, C. M., Torgersen, L., Lupattelli, A., & Petersen, L. V. (2022) · International Journal of Eating Disorders · doi:10.1002/eat.23877 · Cited by 1
Psychotropic Drugs in Pregnancy and Breastfeeding
Orsolini, L., & Bellantuono, C. (2022) · Springer eBooks · doi:10.1007/978-3-030-91832-3_16 · Cited by 1
Timing of selective serotonin reuptake inhibitor use and risk for preterm birth and related adverse eventsPreprint
Hwang, Y. M., Roper, R. T., Piekos, S. N., Enquobahrie, D. A., Hebert, M. F., Paquette, A. G., Baloni, P., Price, N. D., Hood, L., & Hadlock, J. (2023) · medRxiv · doi:10.1101/2023.03.03.23286717 · Cited by 1
Early comorbid parental depression and its effects on child outcomes
Wijlaars, L. P. M. M. (2014) · UCL Discovery (University College London)
Promise and peril: Dissemination of findings from studies of drugs used in pregnancy and their association with birth defects
Patrick, S. W., & Cooper, W. O. (2015) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.23409
On being a Doctor … and work in Harvard
Hernández–Dı́az, S. (2014) · Revista Clínica Española · doi:10.1016/j.rce.2014.03.012
SSRI Use in Pregnancy and Congenital Heart Defects: A Meta-Analysis of Population Based Cohort Studies
Kowalik, E. A. (2016) · Journal of Media Literacy Education
Screening for Depression Through a Glass Darkly—Reply
Olfson, M., Blanco, C., & Marcus, S. C. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9287
Use of antidepressants during pregnancy among women in Iceland 2003 - 2012: A nationwide population-based study
Baldvinsdóttir, D. (2016)
The problem of depression in women with epilepsy during pregnancy and after childbirth
Melikova, S. Y. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201911911270
Attention-Deficit/Hyperactivity Disorder in Children Following Prenatal Exposure to Antidepressants: results from the Norwegian Mother, Father and Child Cohort StudyPreprint
Lupattelli, A., Mahic, M., Handal, M., Ystrøm, E., Reichborn‐Kjennerud, T., & Nordeng, H. (2020) · doi:10.22541/au.160133485.51800404
ウエイトトレーニング時のウォーミングアップ(2)クイックリフト実施時の各種競技アスリートの実践例
槇野, 陽., 下嶽, 進., & 砂川, 力. (2008)
Major Depression
Rasminsky, S., Barzilay, E. M., & Burt, V. K. (2019) · Springer eBooks · doi:10.1007/978-3-319-92919-4_13
Psychiatric disease
Simoni, M. K., & Yonkers, K. A. (2018) · Wiley eBooks · doi:10.1002/9781119072980.ch36
Prevalence of Selective Serotonin Reuptake Inhibitor Use Among Pregnant Women From 2017 to 2020 in King Abdulaziz Medical City, Jeddah, Saudi Arabia: A Retrospective Study
Hakami, A. Y., Ahmad, R. G., Bukhari, M. M., Almalki, M. A., Ahmed, M. M., Alghamdi, M., Kalantan, M. A., & Alsulami, K. M. (2023) · Cureus · doi:10.7759/cureus.47745
Prevalence of benzodiazepines use during pregnancy in Lebanon
Sargi, J., Hachem, C. E., Richa, S., & Amil, C. E. (2024) · L Encéphale · doi:10.1016/j.encep.2024.02.009
Neonatal therapy after maternal central neurotropic drug exposure—a retrospective cohort study
Wecker, S. N., Dammert, A. S., Scholz, C., Krüger, M., Hauer, J., & Brickmann, C. (2024) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2024.2356038
How early childhood stress relates to parents’ involvement in children’s daily lives: a longitudinal study
Gungordu, N., Hernandez‐Reif, M., & DeCaro, J. A. (2025) · Early Child Development and Care · doi:10.1080/03004430.2025.2484215
A Review of Neonatal Selective Serotonin Reuptake Inhibitor Withdrawal Syndrome
Mamillapalli, L., Lu, S., Witkin, J., Gavaskar, R., Cheng, A., McIntyre, K., Aboujaoude, E. R., Gonzalez, J., Siu, A., & Sturgill, M. G. (2025) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/jppt-24-00010
Major Depression
Rasminsky, S., & Burt, V. K. (2025) · Springer eBooks · doi:10.1007/978-3-031-99720-4_15
General Approach to Psychopharmacological Treatment During the Perinatal Period
Bellantuono, C. (2025) · Springer eBooks · doi:10.1007/978-3-031-99720-4_4
The effect of sertraline and voluntary exercise during pregnancy on litter characteristics and postpartum affective behaviour in rat dams
Jarbou, N. S., Mairinger, O., Kulen, E., Mushahwar, L., Walpole, S. J., Matthews, J., Maksour, S., Weston–Green, K., Dottori, M., & Newell, K. A. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111520
Side effects of antidepressant use in pregnancy
Hughes, C., Avoundjian, A., & Haghparast, P. (2025) · Side effects of drugs annual · doi:10.1016/bs.seda.2025.09.009
Use of antidepressants before, during, and after pregnancy between 2015 and 2021 in Switzerland: a retrospective analysis of Swiss health care claims data
Danelli, A., Marxer, C. A., Graber, S. M., Huber, C., Zürcher, S. J., Panchaud, A., Surbek, D., Meier, C. R., & Spoendlin, J. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121483
Recurrent Profound Hypothermia as a Presentation of Neonatal Adaptation Syndrome Following In Utero Fluvoxamine Exposure: A Case Report
Nguyen, H., Doctor, D., & Vaisberg, E. (2026) · Case Reports in Pediatrics · doi:10.1155/crpe/1546965

Authors: Huybrechts, K. F., Palmsten, K., Mogun, H., Kowal, M., Avorn, J., Setoguchi-Iwata, S., & Hernández-Díaz, S.
Affiliations: Brigham and Women's Hospital (US)
Harvard University (US)
Duke University (US)
Corresponding author: Huybrechts, Krista F.
ORCID: Huybrechts, Krista F.
Palmsten, Kristin
Avorn, Jerry
Venue: General Hospital Psychiatry
Publisher: Elsevier BV
Published: 2013-05
Volume: 35
Issue: 3
Pages: 265-271
ISSN: 0163-8343 (ISSN-L)
DOI: 10.1016/j.genhosppsych.2012.12.010
PMC: PMC4077674
OpenAlex: W2114602840
Cited by: 161
References: 38
Citations by year: 2026: 2 · 2025: 10 · 2024: 8 · 2023: 10 · 2022: 14 · 2021: 13 · 2020: 19 · 2019: 16 · 2018: 16 · 2017: 14 · 2016: 11 · 2015: 12 · 2014: 12 · 2013: 3
FWCI: 12.92
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: General Hospital Psychiatry (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Child Health and Human Development
National Institutes of Health
Agency for Healthcare Research and Quality (T32HD060454, R01 HSO18533)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
Keywords: antidepressant use in pregnancy, maternal depression, Medicaid, regional variation in treatment, racial disparities, temporal trends
MeSH terms: Adolescent, Adult, Antidepressive Agents, Child, Depressive Disorder, Female, Humans, Medicaid, Middle Aged, Pregnancy, Pregnancy Complications, United States, Cohort Studies, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

National trends in antidepressant medication treatment among publicly insured pregnant women

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks